ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Catheter-Based Treatments

June 18, 2019
This large review of over 100,000 patients undergoing transcatheter aortic valve replacement demonstrated a stroke rate of 2.3% within 30 days of the procedure, and no decrease in the rate between 2011 and 2015.
May 24, 2019
Patient Care and General Interest Despite being the leading cause of death in the US, heart disease was the most-Googled disease in only one state: Maine.
May 2, 2019
Find the Transcatheter Heart Valves Greece 2019 livestreams here on-demand..
April 20, 2019
The American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), American Society of Echocardiography (ASE), Society for Cardiovascular Angiography and Interventions (SCAI), and Society of Thoracic Surgeons (STS) published a joint expert consensus and evidence-based recommendations for systems of care related to valvular he
April 13, 2019
The Stanford University cardiac surgery team expounds on current evidence for selection of prostheses in valve replacement. While more liberal usage of biologic prostheses in younger patients may be appropriate for the aortic valve, the support for this practice in the mitral position is not as strong.
April 8, 2019
This review provides a comprehensive overview of the available data on antithrombotic therapy after transcatheter aortic valve replacement.
April 5, 2019
Mick Jagger has undergone a TAVR procedure in New York and is now recovering.
April 3, 2019
In light of the recent Centers for Medicare and Medicaid Services recommendation for transcatheter aortic valve replacement (TAVR) volumes, this study looked at 113,662 TAVRs from the TVT registry from 2015 to 2017 and found that 30-day mortality was higher at low-volume TAVR hospitals or low-volume operators.
March 18, 2019
A number of interesting findings in early follow up of this randomized controlled trial on one type of transcatheter aortic valve against conventional surgery: the mechanics of the valve and the incidence of complete heart block, to name but a few. We await the longer follow up.
March 15, 2019
Drugs and Devices The US Food and Drug Administration (FDA) announced that the indications for the MitraClip™, made by Abbott, have been expanded to include secondary mitral regurgitation.

Pages